• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生长抑素对体外培养的无功能垂体肿瘤细胞血管内皮生长因子(VEGF)分泌的影响。

Effects of somatostatin on vascular endothelial growth factor (VEGF) secretion from non-functioning pituitary tumoral cells incubated in vitro.

作者信息

Ławnicka Hanna, Pisarek Hanna, Kunert-Radek Jolanta, Pawlikowski Marek

机构信息

Department of Immunoendocrinology, Chair of Endocrinology, Medical University of Lodz, Poland.

出版信息

Neuro Endocrinol Lett. 2008 Feb;29(1):113-6.

PMID:18283262
Abstract

OBJECTIVES

The aim of the study was to examine the effect of somatostatin (SST) on vascular endothelial growth factor (VEGF) secretion from clinically non-functioning pituitary tumors incubated in vitro.

MATERIAL AND METHODS

Eight pituitary tumors surgically removed were investigated. All of the tumors were diagnosed before surgery as non-functioning. Seven of them were diagnosed after surgery as pituitary adenomas and expressed either gonadotropins or their subunits as detected by immunohistochemistry. Two tumors additionally expressed prolactin and growth hormone. One tumor was immunonegative for pituitary hormones and was diagnosed as haemangiopericytoma. All tumors but one were investigated immunohistochemically to detect the somatostatin receptors and expressed at least 3 of 5 subtypes of somatostatin receptors. The cells isolated from the examined tumors were exposed in vitro to native SST-14. The concentration of VEGF in the culture media was performed by means of ELISA method.

RESULTS

It was found that the exposure on SST-14 resulted in the divergent changes (increase in 4 cases and decrease in 3 cases) in VEGF concentrations in the medium. It seems that the inhibition of VEGF secretion is related to the expression of somatostatin receptor subtypes sst1 and sst2.

CONCLUSIONS

The response of VEGF secretion from pituitary tumoral cells to SST seems to depend on the spectrum of expressed somatostatin receptor subtypes. However, this presumption needs further studies on the larger material.

摘要

目的

本研究旨在探讨生长抑素(SST)对体外培养的临床无功能垂体瘤血管内皮生长因子(VEGF)分泌的影响。

材料与方法

对手术切除的8例垂体瘤进行研究。所有肿瘤术前均诊断为无功能肿瘤。其中7例术后诊断为垂体腺瘤,免疫组化检测显示表达促性腺激素或其亚基。另外2例肿瘤还表达催乳素和生长激素。1例肿瘤垂体激素免疫阴性,诊断为血管外皮细胞瘤。除1例肿瘤外,所有肿瘤均进行免疫组化检测生长抑素受体,表达至少5种生长抑素受体亚型中的3种。从所检查的肿瘤中分离出的细胞在体外暴露于天然SST-14。通过ELISA法检测培养基中VEGF的浓度。

结果

发现暴露于SST-14导致培养基中VEGF浓度出现不同变化(4例升高,3例降低)。VEGF分泌的抑制似乎与生长抑素受体亚型sst1和sst2的表达有关。

结论

垂体瘤细胞VEGF分泌对SST的反应似乎取决于所表达的生长抑素受体亚型谱,但这一推测需要对更多样本进行进一步研究。

相似文献

1
Effects of somatostatin on vascular endothelial growth factor (VEGF) secretion from non-functioning pituitary tumoral cells incubated in vitro.生长抑素对体外培养的无功能垂体肿瘤细胞血管内皮生长因子(VEGF)分泌的影响。
Neuro Endocrinol Lett. 2008 Feb;29(1):113-6.
2
Effects of somatostatin-14 and the receptor-specific somatostatin analogs on chromogranin A and alpha-subunit (alpha-SU) release from "clinically nonfunctioning" pituitary adenoma cells incubated in vitro.生长抑素-14及受体特异性生长抑素类似物对体外培养的“临床无功能”垂体腺瘤细胞分泌嗜铬粒蛋白A和α亚基(α-SU)的影响。
J Physiol Pharmacol. 2007 Mar;58(1):179-88.
3
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion.帕西瑞肽是一种多亚型生长抑素受体配体,通过抑制血管内皮生长因子的分泌来降低无功能垂体腺瘤的细胞活力。
Endocr Relat Cancer. 2007 Mar;14(1):91-102. doi: 10.1677/ERC-06-0026.
4
Effects of selective somatostatin analogs and cortistatin on cell viability in cultured human non-functioning pituitary adenomas.选择性生长抑素类似物和促皮质素释放因子对培养的人无功能垂体腺瘤细胞活力的影响。
Mol Cell Endocrinol. 2008 May 14;286(1-2):214-8. doi: 10.1016/j.mce.2007.12.011. Epub 2007 Dec 27.
5
The effect of selective sst1, sst2, sst5 somatostatin receptors agonists, a somatostatin/dopamine (SST/DA) chimera and bromocriptine on the "clinically non-functioning" pituitary adenomas in vitro.选择性sst1、sst2、sst5生长抑素受体激动剂、一种生长抑素/多巴胺(SST/DA)嵌合体及溴隐亭对“临床无功能”垂体腺瘤的体外作用
Life Sci. 2006 Jan 11;78(7):689-93. doi: 10.1016/j.lfs.2005.05.061. Epub 2005 Aug 22.
6
Effects of rosiglitazone--peroxisome proliferators-activated receptor gamma (PPARgamma) agonist on cell viability of human pituitary adenomas in vitro.罗格列酮——过氧化物酶体增殖物激活受体γ(PPARγ)激动剂对人垂体腺瘤细胞活力的体外影响。
Neuro Endocrinol Lett. 2009 Mar;30(1):107-10.
7
Blocking vascular endothelial growth factor-A inhibits the growth of pituitary adenomas and lowers serum prolactin level in a mouse model of multiple endocrine neoplasia type 1.在1型多发性内分泌肿瘤小鼠模型中,阻断血管内皮生长因子-A可抑制垂体腺瘤生长并降低血清催乳素水平。
Clin Cancer Res. 2008 Jan 1;14(1):249-58. doi: 10.1158/1078-0432.CCR-07-1552.
8
Some changes of receptor and postreceptor signal transduction regulated by somatostatin in pituitary hGH-secreting adenomas.垂体生长激素分泌腺瘤中受生长抑素调节的受体及受体后信号转导的一些变化。
Chin Med J (Engl). 1997 Sep;110(9):678-81.
9
Inhibition of hormone secretion in GH-secreting pituitary adenomas by receptor-subtype specific somatostatin analogues in vitro.体外实验中受体亚型特异性生长抑素类似物对生长激素分泌型垂体腺瘤激素分泌的抑制作用
Gen Physiol Biophys. 2003 Jun;22(2):201-12.
10
Genetic abnormalities of somatostatin receptors in pituitary tumors.垂体瘤中生长抑素受体的基因异常。
Mol Cell Endocrinol. 2008 May 14;286(1-2):180-6. doi: 10.1016/j.mce.2007.08.013. Epub 2007 Aug 31.

引用本文的文献

1
Pasireotide is more effective than octreotide, alone or combined with everolimus on human meningioma .帕西瑞肽在治疗人类脑膜瘤方面比奥曲肽单独使用或与依维莫司联合使用更有效。
Oncotarget. 2017 Jul 24;8(33):55361-55373. doi: 10.18632/oncotarget.19517. eCollection 2017 Aug 15.
2
Over-expression of vascular endothelial growth factor in pituitary adenomas is associated with extrasellar growth and recurrence.垂体腺瘤中血管内皮生长因子的过度表达与鞍外生长和复发有关。
Pituitary. 2013 Sep;16(3):370-7. doi: 10.1007/s11102-012-0434-4.